Ebit Değişiklik Tarih
AbbVie USD 6.72B 1.99B 2026-06
Bristol-Myers Squibb USD 299M 3.26B 2026-06
Galectin Therapeutics USD -9.17M 163K 2023-09
Gilead Sciences USD 3.85B 1.17B 2026-06
Immunic USD -23.33M 2.67M 2025-12
Incyte USD 700.4M 356.23M 2026-06
Merck USD 840M 2.72B 2026-06